Active — Not RecruitingNot Applicable

Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries

Egypt120 participantsStarted 2026-01-10

Plain-language summary

This prospective randomized controlled study will be conducted to evaluate the effect of preoperative single, micro-dose of dexmedetomidine (0.3μg/kg) on the incidence and severity of EA in adults undergoing Septoplasty surgeries

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients of both gender aged 18 to 60 years with American Society of Anesthesiologists (ASA) Physical Status I or II, who were scheduled for septoplasty surgery under general anesthesia. Exclusion Criteria: * Patients declined to participate in the trial. * History or clinical evidence of chronic obstructive pulmonary disease. * History of renal or hepatic dysfunction, sleep apnea syndrome. * Cognitive dysfunction or psychiatric disorder. * Patients receiving beta blocker. * Patients with anticipated difficult airway. * Patients with electro cardiac abnormalities. * Emergency surgeries. * Pregnancy.

What they're measuring

Incidence of emergence agitation

Timeframe: incidence of emergence agitation will be assessed by Aono's Four-point Scale (AFPS) after extubation, at PACU arrival, every 5 minutes for the first 15 minutes then every 15 minutes for the first hour after surgery.

Trial details

NCT IDNCT07302815

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-07-10

View on ClinicalTrials.gov More Emergence Agitation trials